Team GreenOverMorrow from Morocco wins with a smart energy management solution to set the energy transition of agriculture in motion The winners receive a 10,000-euro cash prize MISSISSAUGA, Ontario--(BUSINESS WIRE)--Schneider Electric, the leader in
VANCOUVER, British Columbia--(BUSINESS WIRE)--ABOzymes Biomedical Inc., today announced it has completed a substantially upsized seed financing. The funds will be used to further develop its ground-breaking proprietary platform that enables a world where
Canadian-based biotech company adopts internationally recognized standards to enhance environmental performance VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, announced today that it has rec
SASKATOON, Saskatchewan--(BUSINESS WIRE)--#agriculture--Ag-West Bio, Saskatchewan’s bioscience industry association, welcomes anyone with an interest in agriculture and food to join our annual meeting for a discussion about the environmental impact of a
TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and
Authorization is supported by positive results from three completed phase 3 clinical trials that enrolled more than 1000 subjects in the U.S. and Europe TORONTO--(BUSINESS WIRE)--Croma Aesthetics Canada Ltd., doing business as Hugel Aesthetics, today a
TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Kimberly M. Murphy, member of
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerati
IMV achieves predetermined milestone to access the remaining $US10 Million under its Debt Facility with Horizon Phase 2b AVALON trial in platinum-resistant ovarian cancer open for enrollment DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IM
- Company reiterates key pipeline and strategic milestones for 2022 – TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therape
Game Changers is the first report to compile Canada’s extensive activity in alternative protein development in one place.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.